Octarine Bio

Private Company

Company Overview

Octarine Bio is a synthetic biology company developing superior cannabinoid and psilocybin derivatives.

Using a unique biosynthetic platform, the company engineers microorganisms to produce a range of natural and novel cannabinoid and psilocybin derived molecules with improved pharmacokinetic and therapeutic properties.

The company's proprietary enzyme platform technologies efficiently modify molecules, and fermentation platforms to effectively scale-up production.

Management Team


Nethaji Gallage
Founder & CEO

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.